NL-OMON50975
Recruiting
Not Applicable
Test-retest validation of quantitative MRI - test-retest MRI
Antoni van Leeuwenhoek Ziekenhuis0 sites208 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cancer
- Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Enrollment
- 208
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- age \>\= 18 years, who receive an MRI for preparation of their treatment with
- •radiotherapy and/or who receive radiation treatment on the MRL
- •\- WHO performance status 0\-2
- •\- ability to understand and willingness to sign a written informed consent
Exclusion Criteria
- •\- Contra\-indications for an MRI examination
- •\- Pregnancy
- •\- Claustrophobia
- •\- Over 140 kg and/or a body with over 60 cm
- •\- Patients with any other clinically significant medical condition which, in
- •the opinion of the treating physician, makes it undesirable fot the patient to
- •participate in the stydy or which jeopardize compliance with study requirements
- •or severe psychiatric illness/social situation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Test-retest validation of quantitative MRI in healthy volunteersNL-OMON49913Antoni van Leeuwenhoek Ziekenhuis200
Completed
Not Applicable
Test-retest reliability of quantitative MRI parameters in a prospective single-center neurooncological imaging studyIntra-session test-retest reliability of quantitative MRI parameters in neurooncological MRI imaging of the brainC71Malignant neoplasm of brainDRKS00011651Abt. Neuroradiologie - Universitätsklinikum Heidelberg60
Recruiting
Not Applicable
sefulness of quantitative MRI in the evaluation of pancreatic fibrosis and evaluation of residual pancreatic exocrine functiopancreatic tumorJPRN-UMIN000050347Kawasaki Medical School40
Completed
Not Applicable
Test-retest reliability on ePOD fMRI studieshet onderzoek betreft geen aandoeningTest-retest effect on fMRINL-OMON36088Academisch Medisch Centrum
Active, not recruiting
Not Applicable
To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancyEUCTR2004-002053-31-GBHammersmith Hospital100